CardioNet, Inc. Announces Launch of MCOTos 2:1 Device  
6/20/2013 8:52:09 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CONSHOHOCKEN, Pa., June 19, 2013 (GLOBE NEWSWIRE) -- CardioNet, Inc. (Nasdaq:BEAT) ("CardioNet"), the leading wireless medical technology company focused on diagnosing and monitoring cardiac arrhythmias, announced today the launch of the MCOTos 2:1 device, providing both MCOTTM and wEvent monitoring capability in a single device. This added feature provides increased flexibility and convenience to both physicians and patients.

Help employers find you! Check out all the jobs and post your resume.